Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 909-915

  Bjerregaard, Jon K ^a,b   Mortensen, Michael B ^a   Jensen, Helle A ^a   Nielsen, Morten ^a   Pfeiffer, Per ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Chemotherapy; Locally advanced; Neoadjuvant; Pancreatic cancer; Prognosis; Radiotherapy

Indexed keywords

ADVERSE EVENTS; CONFIDENCE INTERVAL; COX REGRESSION; GEMCITABINE; GROSS TUMOR VOLUME; HAZARD RATIO; INTENSIVE THERAPY; LOCALLY ADVANCED; LOGISTIC REGRESSION MODELS; MEDIAN SURVIVAL; NEOADJUVANT; ODDS RATIOS; PANCREATIC CANCERS; PROGNOSIS; PROGNOSTIC FACTORS; PROGNOSTIC MODEL; TUMOR VOLUMES;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; DRUG PRODUCTS; HEMOGLOBIN; LOGISTICS; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

DIAGNOSIS;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; FOLINIC ACID; GEMCITABINE; HEMOGLOBIN; LACTATE DEHYDROGENASE; UFT;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY STENT OBSTRUCTION; BILIARY TRACT DISEASE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COHORT ANALYSIS; CONSTIPATION; DEEP VEIN THROMBOSIS; DEHYDRATION; DIARRHEA; FATIGUE; FEMALE; HUMAN; HYPERGLYCEMIA; INFECTIOUS COMPLICATION; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MULTIMODALITY CANCER THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION INJURY; RADIATION SICKNESS; RETROSPECTIVE STUDY; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; STOMACH PERFORATION; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; HUMANS; LEUCOVORIN; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TEGAFUR; TUMOR BURDEN; URACIL;

EID: 84861193180     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.008     Document Type: Article

References (22)

1. M. Imamura, R. Doi, and T. Imaizumi A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer Surgery 136 2004 1003 1011
2. M.K. Krzyzanowska, J.C. Weeks, and C.C. Earle Treatment of locally advanced pancreatic cancer in the real world: Population-based practices and effectiveness J Clin Oncol 21 2003 3409 3414
3. K.Y. Bilimoria, D.J. Bentrem, and C.Y. Ko Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database Cancer 110 2007 738 744
4. H.R. Cardenes, E.G. Chiorean, and J. Dewitt Locally advanced pancreatic cancer: Current therapeutic approach Oncologist 11 2006 612 623
5. A. Sultana, S.C. Tudur, and D. Cunningham Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy Br J Cancer 96 2007 1183 1190
6. A. Sultana, C.T. Smith, and D. Cunningham Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer J Clin Oncol 25 2007 2607 2615
7. A. Sultana, S.C. Tudur, and D. Cunningham Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: Results of secondary end points analyses Br J Cancer 99 2008 6 13
8. T.B. Brunner, D. Tinkl, and G.G. Grabenbauer Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: A retrospective analysis of prospectively recruited patients Strahlenther Onkol 182 2006 210 215
9. H. Shinchi, S. Takao, and H. Noma Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 53 2002 146 150
10. J.D. Allendorf, M. Lauerman, and A. Bill Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: Feasibility, efficacy, and survival J Gastrointest Surg 12 2008 91 100
11. J.K. Bjerregaard, M.B. Mortensen, and H.A. Jensen Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer Radiother Oncol 92 2009 226 230
12. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
13. S. Gillen, T. Schuster, and B.C. Meyer Zum Preoperative/neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of response and resection percentages PLoS Med 7 2010 e1000267
14. B. Chauffert, F. Mornex, and F. Bonnetain Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study Ann Oncol 19 2008 1592 1599
15. P.J. Loehrer Sr., M.E. Powell, and H.R. Cardenes A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 J Clin Oncol (Meeting Abstracts) 26 2008 4506
16. P.J. Loehrer Sr., Y. Feng, and H. Cardenes Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial J Clin Oncol 2011 [epub ahead of print]
17. F. Huguet, T. Andre, and P. Hammel Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies J Clin Oncol 25 2007 326 331
18. S. Krishnan, V. Rana, and N.A. Janjan Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy Cancer 110 2007 47 55
19. D.D. Stocken, A.B. Hassan, and D.G. Altman Modelling prognostic factors in advanced pancreatic cancer Br J Cancer 99 2008 883 893
20. S. Mallett, P. Royston, and R. Waters Reporting performance of prognostic models in cancer: A review BMC Med 8 2010 21
21. S. Mallett, P. Royston, and S. Dutton Reporting methods in studies developing prognostic models in cancer: a review BMC Med 8 2010 20
22. T. Yoo, W.J. Lee, and S.M. Woo Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 81 2011 e623 e630